Covestor LTD Design Therapeutics, Inc. Transaction History
Covestor LTD
- $157 Million
- Q1 2024
A detailed history of Covestor LTD transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 32 shares of DSGN stock, worth $130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32
Previous 34
5.88%
Holding current value
$130
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DSGN
# of Institutions
94Shares Held
30.5MCall Options Held
100Put Options Held
100-
Sr One Capital Management, LP6.53MShares$26.6 Million8.85% of portfolio
-
Logos Global Management LP San Francisco, CA5.03MShares$20.5 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.27MShares$9.26 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.66MShares$6.76 Million0.08% of portfolio
-
Tang Capital Management LLC San Diego, CA1.48MShares$6.03 Million0.73% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $227M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...